CSPC Pharmaceutical Group

CSPC Pharmaceutical Group, established in 1997, is a prominent investment holding company operating within the Pharmaceuticals and Healthcare sectors. The company is primarily engaged in the manufacturing and selling of pharmaceutical products, serving diverse market needs. Its business segments include Finished Drugs, Antibiotics, Vitamin C, Caffeine, and Others, demonstrating a broad portfolio. CSPC Pharmaceutical Group is committed to advancing healthcare solutions through its extensive operations. Learn about CSPC Pharmaceutical Group's global headquarters for detailed geographic information.

With a substantial workforce exceeding 10,000 employees, CSPC Pharmaceutical Group operates at a significant scale. The company's revenue reached $4.0B, underscoring its market impact and operational capacity. Its product offerings encompass a wide range of pharmaceutical items, contributing to public health and well-being. The organization focuses on research, development, and production to deliver high-quality medicines. Meet CSPC Pharmaceutical Group's team to understand the leadership driving its strategic initiatives and operational excellence.

The company is publicly traded under the ticker OTC: CHJTF. While the provided data indicates a location count of zero, CSPC Pharmaceutical Group's extensive reach and market presence are evident through its product distribution and industry standing. Its strategic focus on innovation and quality positions it as a key player in the global pharmaceutical landscape, dedicated to improving patient outcomes and contributing to the healthcare ecosystem.